Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Therapy areas
Musculoskeletal
Musculoskeletal
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Musculoskeletal
Terumo’s PLAJEX Provides a Solution for a New Osteoporosis Treatment Developed and Manufactured on Contract
Firstwordpharma News
-
December 11, 2019
Musculoskeletal
Fulcrum Therapeutics Licenses Failed GSK Drug for Possible Muscular Dystrophy Indication
Musculoskeletal
Study links Celebrex, heart valve calcification after earlier research declared drug safe
Musculoskeletal
The delicate balance of treating growing but brittle bones
Musculoskeletal
Drug shows promise to treat diet-induced osteoarthritis
Musculoskeletal
Despite concerns, opioids remain legitimate pain medications, says Health Canada ...
Firstwordpharma News
-
December 7, 2018
0
- Advertisement -
MOST POPULAR
Drug profiling and gene scissors open new avenues in immunotherapy
January 22, 2020
First Patient Dosed in Phase 1 Clinical Study of Tafasitamab in...
December 27, 2019
Exclusive: Take Heart! Life Science Industry Optimistic About Treating Heart Diseases
February 11, 2019
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
March 13, 2019
Load more
HOT NEWS
Others
SIIPL-PCV Vaccine Affordable, Effective, Safe for Immunising Children Against Pneumococcus: Presented...
Others
Hexavalent DTaP-IPV-Hib-HepB Vaccine Safe and Effective in Premature Infants: Presented at...
Others
Novel Progestin Segesterone Contraceptive Vaginal Ring Effective for 1 Year: Presented...
Commercial
Eisai to Present Data on Oncology Pipeline and Products at 55th...
